This same study, however, also observed that intensive insulin therapy was associated with weight gain and, among those classified as excessive weight gainers, the benefits of intensive insulin therapy were substantially diminished, with no difference in cardiovascular disease risk or mortality between those on intensive insulin therapy who gained excessive weight and those on conventional therapy at 6 years follow-up [4,5]. The gene discussed is INS; the disease is cardiovascular disorder.